Loading...
NPI 1821039793 · Fargo, ND · Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
American Drug Stores Delaware LLC is a pharmacy provider located in Fargo, North Dakota. This profile covers 10 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | American Drug Stores Delaware LLC |
| Address | 2425 13th Ave S |
| City | Fargo |
| State | ND |
| ZIP | 58103 |
| Taxonomy | Pharmacy |
| NPI Enumerated | June 9, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $244.5K |
| Medicaid | $3.2K |
AMERICAN DRUG STORES DELAWARE LLC presents as a retail pharmacy operation with immunization and point‑of‑care testing activity as its primary Medicare service lines. The top Medicare revenue codes are vaccine‑related (91320, 90694) and vaccine administration (90480), and the code mix also includes influenza administration G0008 and antigen testing K1034, which together indicate a focus on seasonal and COVID‑19 immunization plus OTC/rapid testing services rather than complex medical procedures.
Revenue is heavily concentrated in a small number of Medicare codes: the precomputed top 3 Medicare codes by revenue account for 70.9% of the provider’s total Medicare revenue. Specifically, 91320 alone contributes $94.7K (38.6% of Medicare revenue) and 90694 contributes $49.7K (20.2%), underscoring that a few vaccine products drive most Medicare dollars for this NPI.
By payer scale, Medicare dominates this provider’s billed business: total Medicare revenue is $244.5K versus total Medicaid revenue of $3.2K, indicating Medicare accounts for the overwhelming share of publicly billed revenue and the provider is effectively a Medicare‑driven operation in scope.
Competitive standing on key Medicare codes is relatively strong by national rank but characterized in the data as typical volume: 91320 ranks #153 of 27083 providers nationally (99th percentile; typical, unremarkable volume for this code), 90694 ranks #360 of 51679 (99th percentile; typical, unremarkable volume for this code), and 90480 ranks #338 of 46950 (99th percentile; typical, unremarkable volume for this code). These high percentile ranks place the provider among the upper tier of billers for these vaccine codes even while the dataset notes the activity level as typical for providers who offer these services.
Medicaid activity is minimal and narrowly concentrated: the precomputed top 3 Medicaid codes by revenue account for 100.0% of this provider’s Medicaid revenue, and A4253 (blood glucose test strips) alone represents 100.0% of Medicaid revenue at $2.9K and 582 claims. A4253 ranks #3 of 7 providers in‑state (67th percentile; typical, unremarkable volume for this code), indicating modest participation in the state Medicaid market for diabetes supplies.
The provider’s service mix suggests a retail pharmacy workflow that pairs vaccination administration with ancillary retail diagnostics: high counts for vaccine product codes (91320, 90694) alongside large administration counts (90480, G0008) and substantial nonprescription test billing (K1034) point to walk‑in immunization clinics and point‑of‑care testing as primary revenue drivers.
Tenure data show this NPI was enumerated on 2006-06-09 (~20 years ago), indicating a long‑standing presence in the market which may support established patient foot traffic and payer relationships that facilitate recurring seasonal vaccination and testing volumes.
While several Medicare code ranks are in high national percentiles, the dataset repeatedly labels these volumes as 'typical, unremarkable' for the codes listed; this suggests the provider achieves above‑median volume among peers for common retail pharmacy services without showing unusual or exceptional coding patterns beyond normal operational scale.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 740 | $130 | $94.7K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 650 | $80 | $49.7K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 740 | $40 | $29.6K |
| G0008 | Administration of influenza virus vaccine | 790 | $30 | $23.7K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 70 | $280 | $20.7K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,230 | $10 | $14.7K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 110 | $70 | $8.1K |
| 0124A | N/A | 70 | $40 | $2.7K |
| G0009 | Administration of pneumococcal vaccine | 80 | $10 | $1.1K |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 20 | $30 | $530 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 580 | $10 | $2.9K |
How this provider's Medicaid billing volume and revenue compare to other North Dakota providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. North Dakota median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 3 | 10 | 200 | $1 | $1.3K |
Other providers in the same ZIP code as American Drug Stores Delaware LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.